Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Lipid Nutrition Market by Type (Omega-3, MCT, Omega-6, Others), by Source (Marine, Plant) and by Application (Dietary Supplements, Infant Formula, Food Beverages, Pharmaceuticals, Animal Feed, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A16145

Pages: NA

Charts: NA

Tables: NA

Lipids are hydrocarbon compounds found in fats, oils, waxes, some vitamins, hormones, and other substances. They are the components that make up the structure and function of live cells. As lipids are non-polar, they are insoluble in water; however, they are soluble in chloroform, a non-polar solvent. Lipids are a good source of energy as when they are digested; the hydrocarbons in them oxidize and release a lot of energy. Hydrocarbons in the reduced form of oils, fats, waxes, some hormones, and vitamins are abundant in lipids. They serve as the foundation for the structure and function of live cells. Because lipids are non-polar, they are insoluble in water, but they are soluble in chloroform. Lipids are a good source of energy that the body can store in large quantities.

COVID-19 Impact Analysis

  • With rise in prevalence of COVID 19, patients' consumption of fatty nutritional products has increased in order to speed up their recovery from infection.
  • Many countries throughout the world have implemented severe lockdown policies to combat the pandemic's spread, which has hampered commercial operations. The shutting of the marketplace has drastically disturbed the demand for and supply of raw materials, as well as product manufacturing and distribution.
  • Transportation, energy, manufacturing, and other industries have all incurred significant financial losses. During the pandemic, however, lipid nutrition played a critical role in giving energy to the human body.

Top Impacting Factors

  • Increased consumer awareness of the benefits of a healthy fat diet and demand for lipid-containing dietary supplements has resulted in an increase in lipid nutrition consumption.
  • Increased need for nutrition from the elderly, increased use of lipid nutrition in food supplements and infant formulae, the incidence of chronic health conditions, and rising obesity among people are all driving demand for lipid nutrition.
  • Consumer interest in preventive healthcare is expanding, as is awareness of lipid nutrition and its health benefits, as well as an increase in the number of chronic health conditions. These are some of the drivers projected to fuel market expansion.

Market Trends

Health consciousness among consumers driving the demand

One of the primary factors driving the growth of the Lipid Nutrition (Nutritional Lipids) Market is the rising incidence of cardiovascular illnesses and obesity. According to the World Health Organization (WHO), over 17 million people died from cardiovascular disease in 2015, with coronary heart disease accounting for the majority of deaths. Furthermore, cardiovascular diseases account for more than 75% of mortality in low and middle-income nations.

In 2016, the World Health Organization (WHO) reported over 600 million instances of obesity among persons aged 18 and above, and over 300 million cases among children aged 5 to 19. Consumers have been more sensitive of their health and well-being as a result of such incidents, and their attention has switched to the intake of fatty nutrition products. As a result, manufacturers have been pushed to participate in research and development operations in order to introduce products with new characteristics.

North America dominating the market and Asia-pacific to become market leader

With rise in prevalence of diabetes and obesity, which necessitates a nutritious diet, North America holds a significant market share. The regional market is predicted to increase due to the growing food and beverage industry and favorable laws for dietary supplements. During the projection period, Asia Pacific is expected to increase significantly. The dietary supplement and pharmaceutical industries are booming in developing economies like India and China, which is propelling the market forward. 
Furthermore, as women's and infants' health concerns have grown, regional need for nutritional lipids has increased. The Asia-Pacific market was dominated by China. At the same time, countries like India, Japan, and South Korea are among the fastest-growing markets, owing to the rising infant and women's nutrition markets. Furthermore, as the Asia-Pacific Lipid Nutrition (Nutritional Lipids) Market is quickly increasing, international firms are investing heavily in the food sector.

Key Benefits of the Report

  • This study presents the analytical depiction of the Lipid Nutrition industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Lipid Nutrition Marketshare.
  • The current market is quantitatively analyzed  to highlight the Lipid Nutrition Marketgrowth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed Lipid Nutrition Marketanalysis based on competitive intensity and how the competition will take shape in coming years

Questions Answered in the Report

  • Which are the leading players active in the Lipid Nutrition Market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is Lipid Nutrition Marketprediction in the future?
  • Which will be the niches at which players profiling with recent advancements should set a presence?
  • What are the driving factors and opportunities in the market?
  • What are the current trends and predicted trends?
  • What are the challenges faced in the Lipid Nutrition Market?

 Key Market Segments

  • By Type
    • Omega-3
    • MCT
    • Omega-6
    • Others
  • By Source
    • Marine
    • Plant
  • By Application
    • Dietary Supplements
    • Infant Formula
    • Food & Beverages
    • Pharmaceuticals
    • Animal Feed
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa

 
Key Market Players

  • Smith & Zoon,
  • Aker Bio Marine
  • Polaris,
  • FMC Corporation,
  • Archer Daniels Midland Company,
  • BASF SE,
  • Pharma marine AS,
  • Cargill, Incorporated,
  • Croda International Plc,
  • Solutex GC,
  • Koninklijke DSM N.V.,
  • Stepan Company,

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: LIPID NUTRITION MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Omega-3

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. MCT

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Omega-6

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: LIPID NUTRITION MARKET, BY SOURCE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Source

    • 5.2. Marine

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Plant

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: LIPID NUTRITION MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Dietary Supplements

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Infant Formula

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Food And Beverages

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Pharmaceuticals

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Animal Feed

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Others

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

  • CHAPTER 7: LIPID NUTRITION MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Source

      • 7.2.4. Market Size and Forecast, By Application

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Lipid Nutrition Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Source
        • 7.2.6.3. Market Size and Forecast, By Application

      • 7.2.7. Canada Lipid Nutrition Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Source
        • 7.2.7.3. Market Size and Forecast, By Application

      • 7.2.8. Mexico Lipid Nutrition Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Source
        • 7.2.8.3. Market Size and Forecast, By Application

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Source

      • 7.3.4. Market Size and Forecast, By Application

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Lipid Nutrition Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Source
        • 7.3.6.3. Market Size and Forecast, By Application

      • 7.3.7. Germany Lipid Nutrition Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Source
        • 7.3.7.3. Market Size and Forecast, By Application

      • 7.3.8. Italy Lipid Nutrition Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Source
        • 7.3.8.3. Market Size and Forecast, By Application

      • 7.3.9. Spain Lipid Nutrition Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Source
        • 7.3.9.3. Market Size and Forecast, By Application

      • 7.3.10. UK Lipid Nutrition Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Source
        • 7.3.10.3. Market Size and Forecast, By Application

      • 7.3.11. Russia Lipid Nutrition Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Source
        • 7.3.11.3. Market Size and Forecast, By Application

      • 7.3.12. Rest Of Europe Lipid Nutrition Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Source
        • 7.3.12.3. Market Size and Forecast, By Application

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Source

      • 7.4.4. Market Size and Forecast, By Application

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Lipid Nutrition Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Source
        • 7.4.6.3. Market Size and Forecast, By Application

      • 7.4.7. Japan Lipid Nutrition Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Source
        • 7.4.7.3. Market Size and Forecast, By Application

      • 7.4.8. India Lipid Nutrition Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Source
        • 7.4.8.3. Market Size and Forecast, By Application

      • 7.4.9. South Korea Lipid Nutrition Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Source
        • 7.4.9.3. Market Size and Forecast, By Application

      • 7.4.10. Australia Lipid Nutrition Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Source
        • 7.4.10.3. Market Size and Forecast, By Application

      • 7.4.11. Thailand Lipid Nutrition Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Source
        • 7.4.11.3. Market Size and Forecast, By Application

      • 7.4.12. Malaysia Lipid Nutrition Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Source
        • 7.4.12.3. Market Size and Forecast, By Application

      • 7.4.13. Indonesia Lipid Nutrition Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Source
        • 7.4.13.3. Market Size and Forecast, By Application

      • 7.4.14. Rest of Asia Pacific Lipid Nutrition Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Source
        • 7.4.14.3. Market Size and Forecast, By Application

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Source

      • 7.5.4. Market Size and Forecast, By Application

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Lipid Nutrition Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Source
        • 7.5.6.3. Market Size and Forecast, By Application

      • 7.5.7. South Africa Lipid Nutrition Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Source
        • 7.5.7.3. Market Size and Forecast, By Application

      • 7.5.8. Saudi Arabia Lipid Nutrition Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Source
        • 7.5.8.3. Market Size and Forecast, By Application

      • 7.5.9. UAE Lipid Nutrition Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Source
        • 7.5.9.3. Market Size and Forecast, By Application

      • 7.5.10. Argentina Lipid Nutrition Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Source
        • 7.5.10.3. Market Size and Forecast, By Application

      • 7.5.11. Rest of LAMEA Lipid Nutrition Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Source
        • 7.5.11.3. Market Size and Forecast, By Application

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Koninklijke DSM N.V.,

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Polaris,

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Archer Daniels Midland Company,

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Stepan Company,

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. BASF SE,

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Solutex GC,

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Smith And Zoon,

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. FMC Corporation,

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Pharma Marine AS,

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Croda International Plc,

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Cargill, Incorporated,

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Aker Bio Marine

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LIPID NUTRITION MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL LIPID NUTRITION MARKET FOR OMEGA-3, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL LIPID NUTRITION MARKET FOR MCT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL LIPID NUTRITION MARKET FOR OMEGA-6, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL LIPID NUTRITION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL LIPID NUTRITION MARKET, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL LIPID NUTRITION MARKET FOR MARINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL LIPID NUTRITION MARKET FOR PLANT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL LIPID NUTRITION MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL LIPID NUTRITION MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL LIPID NUTRITION MARKET FOR INFANT FORMULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL LIPID NUTRITION MARKET FOR FOOD AND BEVERAGES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL LIPID NUTRITION MARKET FOR PHARMACEUTICALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL LIPID NUTRITION MARKET FOR ANIMAL FEED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL LIPID NUTRITION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL LIPID NUTRITION MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA LIPID NUTRITION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. U.S. LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. U.S. LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 23. U.S. LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. CANADA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. CANADA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 26. CANADA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 29. MEXICO LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE LIPID NUTRITION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 36. FRANCE LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 39. GERMANY LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. ITALY LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. ITALY LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 42. ITALY LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 45. SPAIN LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. UK LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. UK LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 48. UK LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC LIPID NUTRITION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. CHINA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. CHINA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 61. CHINA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 64. JAPAN LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. INDIA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. INDIA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 67. INDIA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 76. THAILAND LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA LIPID NUTRITION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. UAE LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 100. UAE LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 101. UAE LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA LIPID NUTRITION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA LIPID NUTRITION, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA LIPID NUTRITION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 108. KONINKLIJKE DSM N.V.,: KEY EXECUTIVES
  • TABLE 109. KONINKLIJKE DSM N.V.,: COMPANY SNAPSHOT
  • TABLE 110. KONINKLIJKE DSM N.V.,: OPERATING SEGMENTS
  • TABLE 111. KONINKLIJKE DSM N.V.,: PRODUCT PORTFOLIO
  • TABLE 112. KONINKLIJKE DSM N.V.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. POLARIS,: KEY EXECUTIVES
  • TABLE 114. POLARIS,: COMPANY SNAPSHOT
  • TABLE 115. POLARIS,: OPERATING SEGMENTS
  • TABLE 116. POLARIS,: PRODUCT PORTFOLIO
  • TABLE 117. POLARIS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. ARCHER DANIELS MIDLAND COMPANY,: KEY EXECUTIVES
  • TABLE 119. ARCHER DANIELS MIDLAND COMPANY,: COMPANY SNAPSHOT
  • TABLE 120. ARCHER DANIELS MIDLAND COMPANY,: OPERATING SEGMENTS
  • TABLE 121. ARCHER DANIELS MIDLAND COMPANY,: PRODUCT PORTFOLIO
  • TABLE 122. ARCHER DANIELS MIDLAND COMPANY,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. STEPAN COMPANY,: KEY EXECUTIVES
  • TABLE 124. STEPAN COMPANY,: COMPANY SNAPSHOT
  • TABLE 125. STEPAN COMPANY,: OPERATING SEGMENTS
  • TABLE 126. STEPAN COMPANY,: PRODUCT PORTFOLIO
  • TABLE 127. STEPAN COMPANY,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. BASF SE,: KEY EXECUTIVES
  • TABLE 129. BASF SE,: COMPANY SNAPSHOT
  • TABLE 130. BASF SE,: OPERATING SEGMENTS
  • TABLE 131. BASF SE,: PRODUCT PORTFOLIO
  • TABLE 132. BASF SE,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. SOLUTEX GC,: KEY EXECUTIVES
  • TABLE 134. SOLUTEX GC,: COMPANY SNAPSHOT
  • TABLE 135. SOLUTEX GC,: OPERATING SEGMENTS
  • TABLE 136. SOLUTEX GC,: PRODUCT PORTFOLIO
  • TABLE 137. SOLUTEX GC,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. SMITH AND ZOON,: KEY EXECUTIVES
  • TABLE 139. SMITH AND ZOON,: COMPANY SNAPSHOT
  • TABLE 140. SMITH AND ZOON,: OPERATING SEGMENTS
  • TABLE 141. SMITH AND ZOON,: PRODUCT PORTFOLIO
  • TABLE 142. SMITH AND ZOON,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. FMC CORPORATION,: KEY EXECUTIVES
  • TABLE 144. FMC CORPORATION,: COMPANY SNAPSHOT
  • TABLE 145. FMC CORPORATION,: OPERATING SEGMENTS
  • TABLE 146. FMC CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 147. FMC CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. PHARMA MARINE AS,: KEY EXECUTIVES
  • TABLE 149. PHARMA MARINE AS,: COMPANY SNAPSHOT
  • TABLE 150. PHARMA MARINE AS,: OPERATING SEGMENTS
  • TABLE 151. PHARMA MARINE AS,: PRODUCT PORTFOLIO
  • TABLE 152. PHARMA MARINE AS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. CRODA INTERNATIONAL PLC,: KEY EXECUTIVES
  • TABLE 154. CRODA INTERNATIONAL PLC,: COMPANY SNAPSHOT
  • TABLE 155. CRODA INTERNATIONAL PLC,: OPERATING SEGMENTS
  • TABLE 156. CRODA INTERNATIONAL PLC,: PRODUCT PORTFOLIO
  • TABLE 157. CRODA INTERNATIONAL PLC,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 158. CARGILL, INCORPORATED,: KEY EXECUTIVES
  • TABLE 159. CARGILL, INCORPORATED,: COMPANY SNAPSHOT
  • TABLE 160. CARGILL, INCORPORATED,: OPERATING SEGMENTS
  • TABLE 161. CARGILL, INCORPORATED,: PRODUCT PORTFOLIO
  • TABLE 162. CARGILL, INCORPORATED,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 163. AKER BIO MARINE: KEY EXECUTIVES
  • TABLE 164. AKER BIO MARINE: COMPANY SNAPSHOT
  • TABLE 165. AKER BIO MARINE: OPERATING SEGMENTS
  • TABLE 166. AKER BIO MARINE: PRODUCT PORTFOLIO
  • TABLE 167. AKER BIO MARINE: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LIPID NUTRITION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LIPID NUTRITION MARKET
  • FIGURE 3. SEGMENTATION LIPID NUTRITION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LIPID NUTRITION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLIPID NUTRITION MARKET
  • FIGURE 11. LIPID NUTRITION MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. LIPID NUTRITION MARKET FOR OMEGA-3, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. LIPID NUTRITION MARKET FOR MCT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. LIPID NUTRITION MARKET FOR OMEGA-6, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. LIPID NUTRITION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. LIPID NUTRITION MARKET SEGMENTATION, BY BY SOURCE
  • FIGURE 17. LIPID NUTRITION MARKET FOR MARINE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. LIPID NUTRITION MARKET FOR PLANT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. LIPID NUTRITION MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 20. LIPID NUTRITION MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. LIPID NUTRITION MARKET FOR INFANT FORMULA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. LIPID NUTRITION MARKET FOR FOOD AND BEVERAGES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. LIPID NUTRITION MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. LIPID NUTRITION MARKET FOR ANIMAL FEED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. LIPID NUTRITION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: LIPID NUTRITION MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. KONINKLIJKE DSM N.V.,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. KONINKLIJKE DSM N.V.,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. KONINKLIJKE DSM N.V.,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. POLARIS,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. POLARIS,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. POLARIS,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. ARCHER DANIELS MIDLAND COMPANY,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. ARCHER DANIELS MIDLAND COMPANY,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. ARCHER DANIELS MIDLAND COMPANY,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. STEPAN COMPANY,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. STEPAN COMPANY,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. STEPAN COMPANY,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. BASF SE,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. BASF SE,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. BASF SE,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. SOLUTEX GC,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. SOLUTEX GC,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. SOLUTEX GC,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. SMITH AND ZOON,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. SMITH AND ZOON,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. SMITH AND ZOON,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. FMC CORPORATION,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. FMC CORPORATION,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. FMC CORPORATION,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. PHARMA MARINE AS,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. PHARMA MARINE AS,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. PHARMA MARINE AS,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. CRODA INTERNATIONAL PLC,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. CRODA INTERNATIONAL PLC,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. CRODA INTERNATIONAL PLC,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 63. CARGILL, INCORPORATED,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 64. CARGILL, INCORPORATED,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 65. CARGILL, INCORPORATED,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 66. AKER BIO MARINE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 67. AKER BIO MARINE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 68. AKER BIO MARINE: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Lipid Nutrition Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved